Literature DB >> 1700052

Human HLA-DR beta gene hypervariable region homology in the biobreeding BB rat: selection of the diabetic-resistant subline as a rheumatoid arthritis research tool to characterize the immunopathologic response to human type II collagen.

W C Watson1, J P Thompson, K Terato, M A Cremer, A H Kang.   

Abstract

Collagen arthritis (CA), an autoimmune model of rheumatoid arthritis (RA), has been studied in various animals. However, it has not been studied in an animal with a genetic background relevant to RA. We selected rats from a diabetic-resistant (DR) subline of the diabetic BB rat because they have an autoimmune disease-prone background, but not the immunodeficiencies of the diabetic BB rat, and the third hypervariable region (HVRIII) of the BB RT1.D beta gene appeared to encode a nucleotide sequence of the human HLA DR beta gene, which has been reported to be associated with susceptibility to RA. We synthesized oligonucleotide primers flanking the RT1.D beta HVRIII, cloned polymerase chain reaction-amplified DNA into M13mp18, and confirmed the presence of the susceptibility sequence (SS) (RRRAA) by the dideoxy sequencing method in a colony of DR BB/Wor-UTM rats. When immunized with human type II collagen (CII) in incomplete Freunds adjuvant (IFA), arthritis developed rapidly by day 10 with 100% incidence. Light and electron microscopy revealed an unusually severe and aggressive, bidirectional pattern of cartilage resorption by synovial and subchondral mononuclear and multinucleated inflammatory cells. These findings coincided with a predominant humoral response to the cyanogen bromide (CB) 11 fragment of the human CII molecule by the pathogenic IgG2a isotype. This study provides further support to the role of CA as a relevant RA model, the specific roles of the CB11 fragment as a major site of arthritogenic epitopes, and of antibody mechanisms in the pathogenesis of CA. Furthermore, the identification of an RA SS in an immune response gene of the DR BB rat presents a novel opportunity to determine with an animal model the role of other antigens as well as this SS in RA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700052      PMCID: PMC2188682          DOI: 10.1084/jem.172.5.1331

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  31 in total

Review 1.  The Epstein-Barr virus glycoprotein gp110, a molecular link between HLA DR4, HLA DR1, and rheumatoid arthritis.

Authors:  J Roudier; G Rhodes; J Petersen; J H Vaughan; D A Carson
Journal:  Scand J Immunol       Date:  1988-04       Impact factor: 3.487

2.  Defective E beta expression in three mouse H-2 haplotypes results from aberrant RNA splicing.

Authors:  F M Tacchini-Cottier; P P Jones
Journal:  J Immunol       Date:  1988-11-15       Impact factor: 5.422

3.  Unaltered class II histocompatibility antigens and pathogenesis of IDDM in BB rats.

Authors:  E W Holowachuk; M K Greer
Journal:  Diabetes       Date:  1989-02       Impact factor: 9.461

Review 4.  Genetic control of specific immune responses.

Authors:  H O McDevitt; B Benacerraf
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

5.  Autoantibody specificities of immune complexes sequestered in articular cartilage of patients with rheumatoid arthritis and osteoarthritis.

Authors:  H E Jasin
Journal:  Arthritis Rheum       Date:  1985-03

6.  Specificity of antibodies to type II collagen in rheumatoid arthritis.

Authors:  K Terato; Y Shimozuru; K Katayama; Y Takemitsu; I Yamashita; M Miyatsu; K Fujii; M Sagara; S Kobayashi; M Goto
Journal:  Arthritis Rheum       Date:  1990-10

7.  Long-term outcome of treating rheumatoid arthritis: results after 20 years.

Authors:  D L Scott; D P Symmons; B L Coulton; A J Popert
Journal:  Lancet       Date:  1987-05-16       Impact factor: 79.321

8.  Elevated mRNA levels of major histocompatibility complex class II genes in lymphocytes of autoimmune BB rats.

Authors:  E W Holowachuk; M K Greer; D R Martin
Journal:  Diabetes       Date:  1988-12       Impact factor: 9.461

9.  Identification of an immunosuppressive epitope of type II collagen that confers protection against collagen-induced arthritis.

Authors:  L K Myers; J M Stuart; J M Seyer; A H Kang
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

10.  Collagen-induced arthritis in mice. Localization of an arthritogenic determinant to a fragment of the type II collagen molecule.

Authors:  K Terato; K A Hasty; M A Cremer; J M Stuart; A S Townes; A H Kang
Journal:  J Exp Med       Date:  1985-08-01       Impact factor: 14.307

View more
  3 in total

1.  Complement C1s activation in degenerating articular cartilage of rheumatoid arthritis patients: immunohistochemical studies with an active form specific antibody.

Authors:  K Nakagawa; H Sakiyama; T Tsuchida; K Yamaguchi; T Toyoguchi; R Masuda; H Moriya
Journal:  Ann Rheum Dis       Date:  1999-03       Impact factor: 19.103

2.  Collagen-induced arthritis in the BB rat. Prevention of disease by treatment with CTLA-4-Ig.

Authors:  D B Knoerzer; R W Karr; B D Schwartz; L J Mengle-Gaw
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

3.  Homologous collagen-induced arthritis in rats and mice are associated with structurally different major histocompatibility complex DQ-like molecules.

Authors:  R Holmdahl; C Vingsbo; H Hedrich; M Karlsson; C Kvick; T J Goldschmidt; K Gustafsson
Journal:  Eur J Immunol       Date:  1992-02       Impact factor: 5.532

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.